Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

I3

Financiado

Innovative Imaging Insights (I3): Development of MR-compatible Bioreactors for T...

Innovative Imaging Insights (I3): Development of MR-compatible Bioreactors for Tissue Engineered Heart Valves Given the escalating global burden of valvular heart disease and the pressing need for living heart valve replacements, I decided to focus my research on this healthcare challenge by acquiring new skills through advanced training... ver más

31/07/2026

PTB

174K€

Presupuesto del proyecto: 174K€

Líder del proyecto

PHYSIKALISCHTECHNISCHE BUNDESANSTALT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-10

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023

I+D

Cerrada hace 1 año

0% 100%

2 Participantes

PTB

173.85K€ | Lider

TU/e

N.D. | Participante

Proyectos interesantes

BIOMITRAL Engineering the mitral valve bioinspired control of structu... 2M€ Cerrado

BioChord biomimetic engineered chordae tendineae for valve repair and... 150K€ Cerrado

G-CYBERHEART Computationally and experimentallY BioEngineeRing the next g... 1M€ Cerrado

GrownValve A prosthetic heart valve for adults and children, made from... 4M€ Cerrado

Aeson® The World’s Only Bioprosthetic Auto-regulated Artificial Hea... 12M€ Cerrado

EUIN2017-88719 RED DE FORMACION INTERDISCIPLINARIA EN REGENERACION CARDIACA... 25K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 27 meses Fecha Inicio: 2024-04-10
Fecha Fin: 2026-07-31

Líder del proyecto

PHYSIKALISCHTECHNISCHE BUNDESANSTALT

TRL 4-5

Presupuesto del proyecto 174K€

Descripción del proyecto Given the escalating global burden of valvular heart disease and the pressing need for living heart valve replacements, I decided to focus my research on this healthcare challenge by acquiring new skills through advanced training and international interdisciplinary collaborations. My proposal I3 combines the design and application of a novel bioreactor for assessing tissue engineered heart valves (TEHVs) by highly advanced magnetic resonance imaging (MRI) to kickstart the innovation cycle in in-vitro experiments. Especially young patients with valvular heart disease will profit from TEHVs as they suffer from current heart valve replacements lacking the ability to self-repair and growth as well requiring the life-long intake of anticoagulants. Leveraging the high-dimensional, non-invasive analysis potential of MRI, my I3 proposal establishes new innovative tools for TEHV research to enable new insights in the resulting hemodynamics downstream of TEHVs, close the optimization loop in-vitro using patient-specific boundary conditions and reduce the need for ethically and monetary challenging animal experiments. Building on my expertise on advanced MRI, I will acquire new skills to develop a novel MRI-compatible bioreactor in the project. Enabling in-vitro experiments with high precision and repeatability, the imaged flow field in the bioreactor allows me to select and optimize a TEHV for specific hemodynamics of patients. In-vivo MRI-enabled feedback of the resulting hemodynamics offers further diagnosis. Furthermore, in-vitro and in-vivo measurements offer important information for optimization of TEHVs for patient-specific treatments. I will use the knowledge and skills gained from this inter-sectoral and inter-disciplinary project for my next career steps (incl. submission of an ERC starting grant) in the field of biomedical engineering research aimed at providing all patients with a suitable heart valve replacement. I3 is a major step towards making this a reality.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores